Terms: = Germ cell tumor AND Ki-67 AND Treatment
797 results:
1. Multi-omics technologies and molecular biomarkers in brain tumor-related epilepsy.
Du Y; Li R; Fu D; Zhang B; Cui A; Shao Y; Lai Z; Chen R; Chen B; Wang Z; Zhang W; Chu L
CNS Neurosci Ther; 2024 Apr; 30(4):e14717. PubMed ID: 38641945
[TBL] [Abstract] [Full Text] [Related]
2. DKK3 Expression in Glioblastoma: Correlations with Biomolecular Markers.
Caffo M; Casili G; Caruso G; Barresi V; Campolo M; Paterniti I; Minutoli L; Ius T; Esposito E
Int J Mol Sci; 2024 Apr; 25(7):. PubMed ID: 38612910
[TBL] [Abstract] [Full Text] [Related]
3. [Clinical features of patients with metastatic pheochromocytoma/paraganglioma].
Cui YY; Zhou Y; Gao YJ; Li TY; Wang Y; Zhang WQ; Zhou T; Chen S; Tong AL
Zhonghua Yi Xue Za Zhi; 2024 Apr; 104(14):1174-1179. PubMed ID: 38583049
[No Abstract] [Full Text] [Related]
4. Ependymomas of the spinal region in adults: Clinical and pathological features and MYCN expression levels in spinal ependymomas and myxopapillary ependymomas.
Topel G; Dirilenoğlu F; Sevin İE; Kahraman A
Ann Diagn Pathol; 2024 Jun; 70():152299. PubMed ID: 38555652
[TBL] [Abstract] [Full Text] [Related]
5. Prediction of disease recurrence in patients after complete pancreatic NET (PanNET) G2 resection.
Olearska H; Sowa-Staszczak A; Morawiec-Sławek K; Kurzyńska A; Kolasa M; Tkacz E; Szumińska M; Hubalewska-Dydejczyk A; Opalinska M
Endokrynol Pol; 2024; 75(1):102-108. PubMed ID: 38497396
[TBL] [Abstract] [Full Text] [Related]
6. Application of Artificial Intelligence in Oncologic Molecular PET-Imaging: A Narrative Review on Beyond [
Eisazadeh R; Shahbazi-Akbari M; Mirshahvalad SA; Pirich C; Beheshti M
Semin Nucl Med; 2024 Mar; 54(2):293-301. PubMed ID: 38331629
[TBL] [Abstract] [Full Text] [Related]
7. Neuroendocrine carcinoma of the uterine cervix with extensive pagetoid spread pattern.
Sakurai A; Yamanoi K; Yamaguchi K; Hamanishi J; Minamiguchi S; Mandai M
J Obstet Gynaecol Res; 2024 Apr; 50(4):758-763. PubMed ID: 38297984
[TBL] [Abstract] [Full Text] [Related]
8. Expression of molecular markers and synergistic anticancer effects of chemotherapy with antimicrobial peptides on glioblastoma cells.
Chernov AN; Kim AV; Skliar SS; Fedorov EV; Tsapieva AN; Filatenkova TA; Chutko AL; Matsko MV; Galimova ES; Shamova OV
Cancer Chemother Pharmacol; 2024 May; 93(5):455-469. PubMed ID: 38280033
[TBL] [Abstract] [Full Text] [Related]
9. Incidental appendiceal neoplasms: Single-centre results.
Ozdemir H; Ozdemir ZU; Gul MO
Indian J Cancer; 2023 Oct; 60(4):542-547. PubMed ID: 38159212
[TBL] [Abstract] [Full Text] [Related]
10. Assessment of ki-67 expression levels in IDH-wildtype glioblastoma using logistic regression modelling of VASARI features.
Bai L; Jiang J; Zhou J
Neurosurg Rev; 2023 Dec; 47(1):20. PubMed ID: 38135816
[TBL] [Abstract] [Full Text] [Related]
11. Whole-Brain Intracellular pH Mapping of Gliomas Using High-Resolution
Paech D; Weckesser N; Franke VL; Breitling J; Görke S; Deike-Hofmann K; Wick A; Scherer M; Unterberg A; Wick W; Bendszus M; Bachert P; Ladd ME; Schlemmer HP; Korzowski A
Radiol Imaging Cancer; 2024 Jan; 6(1):e220127. PubMed ID: 38133553
[TBL] [Abstract] [Full Text] [Related]
12. Patterns of treatment Failure After Selective Rearranged During Transfection (RET) Inhibitors in Patients With Metastatic Medullary Thyroid Carcinoma.
Hadoux J; Al Ghuzlan A; Lamartina L; Bani MA; Moog S; Attard M; Scoazec JY; Hartl D; Aldea M; Friboulet L; Jules-Clement G; Italiano A; Besse B; Lacroix L; Baudin E
JCO Precis Oncol; 2023 Sep; 7():e2300053. PubMed ID: 38127829
[TBL] [Abstract] [Full Text] [Related]
13. Characteristics and treatment options of glucagonomas: a national study from the French Group of Endocrine tumors and ENDOCAN-RENATEN network.
Perrier M; Brugel M; Gérard L; Goichot B; Lièvre A; Lepage C; Hautefeuille V; Do Cao C; Smith D; Thuillier P; Cros J; Cadiot G; Walter T; de Mestier L
Eur J Endocrinol; 2023 Dec; 189(6):575-583. PubMed ID: 38039101
[TBL] [Abstract] [Full Text] [Related]
14. Clinical characteristics and prognostic factors of surgical treatment in children with brainstem tumor.
He YZ; Zhou Q; Deng WY; Huang LY; Lu YY; Ruan YY; Du H
Eur Rev Med Pharmacol Sci; 2023 Nov; 27(22):10926-10934. PubMed ID: 38039022
[TBL] [Abstract] [Full Text] [Related]
15. Quantitative SSTR-PET/CT for predicting response and survival outcomes in patients with pancreatic neuroendocrine tumors receiving CAPTEM.
Ingenerf M; Karim H; Auernhammer C; Zacherl M; Wenter V; Winkelmann M; Ricke J; Berger F; Schmid-Tannwald C
Radiol Oncol; 2023 Dec; 57(4):436-445. PubMed ID: 38038419
[TBL] [Abstract] [Full Text] [Related]
16. Prognostic implications of synaptophysin, CD56, thyroid transcription factor-1, and ki-67 in pulmonary high-grade neuroendocrine carcinomas.
He Y; Zhao L; Tang X; Jiang Q; Zhao X; Cao Y
Ann Diagn Pathol; 2024 Feb; 68():152239. PubMed ID: 38006863
[TBL] [Abstract] [Full Text] [Related]
17. 68 Ga-PSMA-11 PET/CT Imaging in Brain Gliomas and Its Correlation With Clinicopathological Prognostic Parameters.
Verma P; Singh BK; Sudhan MD; Singh RK; Bagul SD; Chandak AR; Soni BK; Shelly D; Basu S
Clin Nucl Med; 2023 Dec; 48(12):e559-e563. PubMed ID: 37883060
[TBL] [Abstract] [Full Text] [Related]
18. Phase II study of everolimus and temozolomide as first-line treatment in metastatic high-grade gastroenteropancreatic neuroendocrine neoplasms.
Morken S; Langer SW; Sundlöv A; Vestermark LW; Ladekarl M; Hjortland GO; Svensson JB; Tabaksblat EM; Haslerud TM; Assmus J; Detlefsen S; Couvelard A; Perren A; Sorbye H
Br J Cancer; 2023 Dec; 129(12):1930-1939. PubMed ID: 37872405
[TBL] [Abstract] [Full Text] [Related]
19. Rare malignant neoplasm of the esophagus: current status and future perspectives.
Yoshinami Y; Nishimura E; Hosokai T; Yamamoto S; Matsuda S; Nomura M; Kawakubo H; Kato K; Kitagawa Y
Jpn J Clin Oncol; 2024 Feb; 54(2):111-120. PubMed ID: 37861097
[TBL] [Abstract] [Full Text] [Related]
20. Optimal first-line treatment strategies of systemic therapy for unresectable gastrointestinal neuroendocrine tumors based on the opinions of Japanese experts.
Honma Y; Ikeda M; Hijioka S; Matsumoto S; Ito T; Aoki T; Furuse J
Invest New Drugs; 2023 Dec; 41(6):777-786. PubMed ID: 37856005
[TBL] [Abstract] [Full Text] [Related]
[Next]
